Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cyclin-dependent kinase inhibitors as marketed anticancer drugs: where are we now? A short survey.
Molecules. 2014 Sep 11;19(9):14366-82. doi: 10.3390/molecules190914366.
Molecules. 2014.
PMID: 25215591
Free PMC article.
Review.
Silver-catalyzed domino hydroarylation/cycloisomerization reactions of ortho-alkynylbenzaldehydes: an entry to functionalized isochromene derivatives.
Mariaule G, Newsome G, Toullec PY, Belmont P, Michelet V.
Mariaule G, et al.
Org Lett. 2014 Sep 5;16(17):4570-3. doi: 10.1021/ol5021256. Epub 2014 Aug 18.
Org Lett. 2014.
PMID: 25133776
Item in Clipboard
Selective binding of oxalate by a tris-ureido calix[6]tube in a protic environment.
Lavendomme R, Moerkerke S, Mariaule G, Jabin I.
Lavendomme R, et al. Among authors: mariaule g.
Org Biomol Chem. 2023 Aug 23;21(33):6730-6737. doi: 10.1039/d3ob00947e.
Org Biomol Chem. 2023.
PMID: 37547927
Item in Clipboard
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, Majem M, González Larriba JL, Provencio Pulla M, Vervita K, Roschitzki-Voser H, Ruepp B, Mitchell P, Stahel RA, Le Pechoux C, De Ruysscher D; ETOP/IFCT 4-12 STIMULI Collaborators.
Peters S, et al.
Ann Oncol. 2022 Jan;33(1):67-79. doi: 10.1016/j.annonc.2021.09.011. Epub 2021 Sep 23.
Ann Oncol. 2022.
PMID: 34562610
Free article.
Clinical Trial.
Item in Clipboard
3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors.
Mariaule G, De Cesco S, Airaghi F, Kurian J, Schiavini P, Rocheleau S, Huskić I, Auclair K, Mittermaier A, Moitessier N.
Mariaule G, et al.
J Med Chem. 2016 May 12;59(9):4221-34. doi: 10.1021/acs.jmedchem.5b01296. Epub 2015 Dec 14.
J Med Chem. 2016.
PMID: 26619267
Item in Clipboard
Cite
Cite